Trade Names: | |
Synonyms: | |
Status: | Approved (2018) |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | N03AX24 |
UNII: | 19GBJ60SN5 |
InChI Key | QHMBSVQNZZTUGM-ZWKOTPCHSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C21H30O2 |
Molecular Weight | 314.47 |
AlogP | 5.85 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 40.46 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 23.0 |
Action | Mechanism of Action | Reference |
---|---|---|
NEGATIVE ALLOSTERIC MODULATOR | Cannabinoid CB1 receptor negative allosteric modulator | PubMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Lennox Gastaut Syndrome | 4 | D065768 | FDA |
Epilepsies, Myoclonic | 4 | D004831 | FDA |
Amyotrophic Lateral Sclerosis | 3 | D000690 | ClinicalTrials |
Psychotic Disorders | 3 | D011618 | ClinicalTrials |
Rett Syndrome | 3 | D015518 | ClinicalTrials |
Fragile X Syndrome | 3 | D005600 | ClinicalTrials |
Spasms, Infantile | 3 | D013036 | ClinicalTrials |
Spasms, Infantile | 3 | D013036 | ClinicalTrials |
Pain | 3 | D010146 | ClinicalTrials |
Osteoarthritis | 3 | D010003 | ClinicalTrials |
Fibromyalgia | 3 | D005356 | ClinicalTrials |
Psychotic Disorders | 3 | D011618 | ClinicalTrials |
HIV Infections | 2 | D015658 | ClinicalTrials |
Alcoholism | 2 | D000437 | ClinicalTrials |
Hepatitis, Autoimmune | 2 | D019693 | ClinicalTrials |
Marijuana Abuse | 2 | D002189 | ClinicalTrials |
Diabetic Neuropathies | 2 | D003929 | ClinicalTrials |
Chronic Pain | 2 | D059350 | ClinicalTrials |
Arthritis, Psoriatic | 2 | D015535 | ClinicalTrials |
Huntington Disease | 2 | D006816 | ClinicalTrials |
Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
Anxiety | 2 | D001007 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Parkinson Disease | 2 | D010300 | ClinicalTrials |
Stress Disorders, Post-Traumatic | 2 | D013313 | ClinicalTrials |
Prader-Willi Syndrome | 2 | D011218 | ClinicalTrials |
Fatty Liver | 2 | D005234 | ClinicalTrials |
Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
Bipolar Disorder | 2 | D001714 | ClinicalTrials |
Tobacco Use Disorder | 2 | D014029 | ClinicalTrials |
Schizophrenia | 2 | D012559 | ClinicalTrials |
Epilepsy, Absence | 2 | D004832 | ClinicalTrials |
Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
Peripheral Nervous System Diseases | 2 | D010523 | ClinicalTrials |
Child Development Disorders, Pervasive | 2 | D002659 | ClinicalTrials |
Autistic Disorder | 2 | D001321 | ClinicalTrials |
Neuralgia | 2 | D009437 | ClinicalTrials |
Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
HIV Infections | 2 | D015658 | ClinicalTrials |
Migraine Disorders | 2 | D008881 | ClinicalTrials |
Obsessive-Compulsive Disorder | 2 | D009771 | ClinicalTrials |
Intellectual Disability | 2 | D008607 | ClinicalTrials |
Status Epilepticus | 1 | D013226 | ClinicalTrials |
Cystitis, Interstitial | 1 | D018856 | ClinicalTrials |
Lung Neoplasms | 1 | D008175 | ClinicalTrials |
Crohn Disease | 1 | D003424 | ClinicalTrials |
Toothache | 1 | D014098 | ClinicalTrials |
Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
Radiculopathy | 1 | D011843 | ClinicalTrials |
Sturge-Weber Syndrome | 1 | D013341 | ClinicalTrials |
Heart Failure | 1 | D006333 | ClinicalTrials |
Essential Tremor | 1 | D020329 | ClinicalTrials |
Anorexia Nervosa | 0 | D000856 | ClinicalTrials |
Cognitive Dysfunction | 0 | D060825 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 13956-29-1 |
ChEBI | 69478 |
ChEMBL | CHEMBL190461 |
DrugBank | DB09061 |
DrugCentral | 5288 |
FDA SRS | 19GBJ60SN5 |
Guide to Pharmacology | 4150 |
PDB | P0T |
PubChem | 644019 |
SureChEMBL | SCHEMBL119679 |
ZINC | ZINC000004097406 |